Gulotta G - Search Results

1

Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers.

Verderame F, Russo A, Di Leo R, Badalamenti G, Santangelo D, Cicero G, Valerio MR, Gulotta G, Tomasello G, Gebbia N, Fulfaro F. Verderame F, et al. Among authors: gulotta g. Ann Oncol. 2006 Jun;17 Suppl 7:vii68-72. doi: 10.1093/annonc/mdl955. Ann Oncol. 2006. PMID: 16760298 Free article. Clinical Trial.

2

Weekly docetaxel as II line therapy in non-small cell lung cancer: an interim analysis of a phase II study.

Valerio MR, Russo A, Latteri MA, Modica G, Gulotta G, Armata MG, Bajardi E, Cicero G, Pantuso G, Grassi N, Agosta G, Gebbia N. Valerio MR, et al. Among authors: gulotta g. Lung Cancer. 2001 Dec;34 Suppl 4:S31-5. doi: 10.1016/s0169-5002(01)00402-0. Lung Cancer. 2001. PMID: 11742700 Clinical Trial.

3

Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

Gargano G, Agnese V, Calò V, Corsale S, Augello C, Bruno L, La Paglia L, Gullo A, Ottini L, Russo A, Fulfaro F, Rinaldi G, Crosta A, Cicero G, Majorana O, Palmeri L, Cipolla C, Agrusa A, Gulotta G, Morello V, Di Fede G, Adamo V, Colucci G, Tomasino RM, Valerio MR, Bazan V, Russo A; Gruppo Oncologico dell'Italia Meridionale. Gargano G, et al. Among authors: gulotta g. Ann Oncol. 2006 Jun;17 Suppl 7:vii41-5. doi: 10.1093/annonc/mdl948. Ann Oncol. 2006. PMID: 16760290 Free article.

4

4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily).

Russo A, Calò V, Augello C, Bruno L, Agnese V, Schirò V, Barbera F, Cascio S, Foddai E, Badalamenti G, Intrivici C, Cajozzo M, Gulotta G, Surmacz E, Colucci G, Gebbia N, Bazan V. Russo A, et al. Among authors: gulotta g. Ann Oncol. 2007 Jun;18 Suppl 6:vi99-102. doi: 10.1093/annonc/mdm235. Ann Oncol. 2007. PMID: 17591844 Free article.

5

Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?

Rizzo S, Bronte G, Fanale D, Corsini L, Silvestris N, Santini D, Gulotta G, Bazan V, Gebbia N, Fulfaro F, Russo A. Rizzo S, et al. Among authors: gulotta g. Cancer Treat Rev. 2010 Nov;36 Suppl 3:S56-61. doi: 10.1016/S0305-7372(10)70021-9. Cancer Treat Rev. 2010. PMID: 21129611 Review.

6

TAS-102 in metastatic colorectal cancer (mCRC): efficacy, tolerability, and quality of life in heavily pretreated elderly patients: a real-life study.

Cicero G, Addeo R, De Luca R, Lo Re G, Gulotta L, Marchesa P, Gulotta G. Cicero G, et al. Among authors: gulotta g, gulotta l. Drugs Context. 2020 Sep 18;9:2020-6-3. doi: 10.7573/dic.2020-6-3. eCollection 2020. Drugs Context. 2020. PMID: 32994802 Free PMC article.

7

EGFR genomic alterations in cancer: prognostic and predictive values.

Bronte G, Terrasi M, Rizzo S, Sivestris N, Ficorella C, Cajozzo M, Di Gaudio F, Gulotta G, Siragusa S, Gebbia N, Russo A. Bronte G, et al. Among authors: gulotta g. Front Biosci (Elite Ed). 2011 Jun 1;3(3):879-87. doi: 10.2741/e296. Front Biosci (Elite Ed). 2011. PMID: 21622099 Free article. Review.

8

Intracavitary treatment of malignant pleural and peritoneal effusions in cancer patients.

Gebbia N, Mannino R, Di Dino A, Maxhouni L, Bellone N, Cinque L, Liuzza A, La Motta P, Cannata G, Gulotta G, et al. Gebbia N, et al. Among authors: gulotta g. Anticancer Res. 1994 Mar-Apr;14(2B):739-45. Anticancer Res. 1994. PMID: 7516642 Review.

9

BRCA1 genetic testing in 106 breast and ovarian cancer families from Southern Italy (Sicily): a mutation analyses.

Russo A, Calò V, Agnese V, Bruno L, Corsale S, Augello C, Gargano G, Barbera F, Cascio S, Intrivici C, Rinaldi G, Gulotta G, Macaluso M, Surmacz E, Giordano A, Gebbia N, Bazan V. Russo A, et al. Among authors: gulotta g. Breast Cancer Res Treat. 2007 Nov;105(3):267-76. doi: 10.1007/s10549-006-9456-9. Epub 2007 Jan 13. Breast Cancer Res Treat. 2007. PMID: 17221156

10

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G, Medema JP, Stassi G. Todaro M, et al. Among authors: gulotta g. Cell Stem Cell. 2007 Oct 11;1(4):389-402. doi: 10.1016/j.stem.2007.08.001. Cell Stem Cell. 2007. PMID: 18371377 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters